Akums Drugs &Pharma, a prominent contract development and manufacturing company in India, launched an ₹1,856-crore IPO with ₹680 crore in fresh issuance. Promoters reduced stakes, and proceeds will tackle debt and working capital. Generating ₹4,178 crore in FY24, Akums serves top pharma brands and stands strong in the expanding market.
Gold, silver ease as investors book profits
Fed Governor Christopher Waller, on the short list to succeed Chair Jerome Powell next year and scheduled to be interviewed for the job by U.S.